Piscataway, NJ, United States of America

Charles A Crichlow

This inventor holds 15 USPTO granted patents, primarily in Benzodiazepine Compounds. Top assignees: Hoechst Roussel Pharmaceuticals, American Hoechst Corporation. Active years: 1980-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles A Crichlow. Retrieved from https://idiyas.com/inventor/charles-a-crichlow

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15

% Patents Active = 100.0

Average Co-Inventor Count = 3.2

ph-index = 4

Forward Citations = 88(Granted Patents)

Location History:

Piscataway, NJ (US) (1980 - 1990)
Stockton, CA (US) (1990 - 1993)

Company Filing History:

12 out of 539

Hoechst Roussel Pharmaceuticals

patents

3 out of 233

American Hoechst Corporation

patents

Years Active: 1980-1993

Loading Chart...

Areas of Expertise:

Benzodiazepines

Antidepressants

Carboxamides

Phenethylamines

Oxime Acetates

Chemical Intermediates

Tranquilizers

Pharmaceuticals

Chemical Processes

Azacycloalkanes

Azacycloalkenes

2-Amino Compounds

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5260339 - 4-phenyl-1,3-benzodiazepines and 2-amino-.alpha.-phenylphenethylamines (1993-11-09),

2. 5185465 - Carboxamides of 2-amino-alpha-phenlphenethylamines (1993-02-09),

3. 4968721 - 2-amino-alpha-phenylphenethylamines and method of use (1990-11-06),

4. 4933493 - Intermediates for the preparation of 4-phenyl-1,3-benzodiazepines (1990-06-12),

5. 4822914 - 2-amino-N-methyl-.alpha.-phenyl-phenethylamines (1989-04-18),

6. 4504680 - 4-Phenyl-1,3-benzodiazepines (1985-03-12),

7. 4469889 - 2-(2-Nitrophenyl)-1-phenylethanone oxime acetates (1984-09-04),

8. 4462933 - Process for preparing 4-phenyl-1,3-benzodiazepines (1984-07-31),

9. 4459231 - Process for preparing 4-phenyl-1,3-benzodiazepines (1984-07-10),

10. 4459230 - Process for preparing 4-phenyl-1,3-benzodiazepines (1984-07-10),

11. 4414219 - Antidepressant (.alpha.-phenyl-2-tolyl)azacycloalkanols and derivatives (1983-11-08),

12. 4409145 - Process for preparing 4-phenyl-1,3-benzodiazepines (1983-10-11),

13. 4311703 - Antidepressant and tranquilizing (.alpha.-phenyl-2-tolyl)-azacycloalkenes (1982-01-19),

14. 4309424 - 4-Phenyl-1,3-benzodiazepines (1982-01-05),

15. 4241071 - Antidepressant (.alpha.-phenyl-2-tolyl)azacycloalkanes (1980-12-23),

Title: Innovations by Inventor Charles A. Crichlow

Introduction

Charles A. Crichlow is an esteemed inventor based in Piscataway, NJ, holding an impressive portfolio of 15 patents. His work primarily focuses on the development of novel pharmaceutical compounds that exhibit significant therapeutic benefits.

Latest Patents

Among his latest innovations are the patents for 4-phenyl-1,3-benzodiazepines and 2-amino-α-phenylphenethylamines. These compounds are described as novel intermediates with methods of preparation that showcase their potential uses as antidepressants, analgesics, and anticonvulsants. In addition, the 2-amino-α-phenylphenethylamines have demonstrated utility as anticonvulsant and neuroprotective agents, contributing to advancements in the field of neurology and mental health.

Career Highlights

Charles A. Crichlow's impressive career includes significant contributions at leading pharmaceutical companies, including Hoechst Roussel Pharmaceuticals and American Hoechst Corporation. Throughout his tenure at these institutions, he has played a crucial role in the advancement of medical technology and drug development.

Collaborations

Crichlow has worked alongside notable colleagues, including Lawrence L. Martin and Manfred Worm, with whom he has collaborated on various projects aimed at creating innovative pharmaceutical solutions. Their combined expertise has further propelled the research and development of effective medical treatments.

Conclusion

In summary, Charles A. Crichlow stands out as a remarkable inventor whose contributions to the pharmaceutical industry have significantly impacted mental health treatment options. His patented innovations continue to pave the way for new therapies, showcasing the importance of creativity and research in addressing complex medical challenges.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]